|
| Press Releases |
|
 |
|
| Tuesday, May 26, 2020 |
|
|
中国生物制药与康方生物共同开发派安普利新药上市申请获国家药品监督管理局受理 |
| 中国领先的创新研发驱动型医药集团 — 中国生物制药有限公司(股份代号:1177)宣布,与致力研究、开发、生产及商业化全球病人可负担的创新抗体新药的生物制药公司康方生物科技(开曼)有限公司(「康方生物」;股份代号:9926) more info >> |
|
|
中國生物製藥與康方生物共同開發派安普利新藥上市申請獲國家藥品監督管理局受理 |
| 中國領先的創新研發驅動型醫藥集團 — 中國生物製藥有限公司(股份代號:1177)宣佈,與致力研究、開發、生產及商業化全球病人可負擔的創新抗體新藥的生物製藥公司康方生物科技(開曼)有限公司(「康方生物」;股份代號:9926) more info >> |
|
|
New Drug Application of Penpulimab Co-developed by Sino Biopharmaceutical and Akeso Accepted by the National Medical Products Administration |
| Sino Biopharmaceutical Limited (HKEX: 1177), a leading, innovative research and development ("R&D") driven pharmaceutical conglomerate in the PRC, has announced that the new drug application of the anti PD-1 monoclonal antibody drug more info >> |
|
| Tuesday, May 19, 2020 |
|
|
中国生物制药与康方生物共同开发派安普利单抗联合安罗替尼一线治疗晚期肝癌的临床试验数据获ASCO年会接受呈列 |
| 中国领先的创新研发驱动型医药集团 — 中国生物制药有限公司(股份代号:1177)宣布,与康方生物科技(开曼)有限公司(「康方生物」;股份代号:9926),共同开发及商业化的派安普利单抗(AK105,PD-1单抗)联合安罗替尼一线治疗晚期肝细胞癌的临床疗效和安全性二期研究数据摘要,获即将召开的2020年美国临床肿瘤学会(ASCO)年会接受以海报形式呈列。 more info >> |
|
|
中國生物製藥與康方生物共同開發派安普利單抗聯合安羅替尼一線治療晚期肝癌的臨床試驗數據獲ASCO年會接受呈列 |
| 中國領先的創新研發驅動型醫藥集團 — 中國生物製藥有限公司(股份代號:1177)宣佈,與康方生物科技(開曼)有限公司(「康方生物」;股份代號:9926),共同開發及商業化的派安普利單抗(AK105,PD-1單抗)聯合安羅替尼一線治療晚期肝細胞癌的臨床療效和安全性二期研究數據摘要,獲即將召開的2020年美國臨床腫瘤學會(ASCO)年會接受以海報形式呈列。 more info >> |
|
|
Results from Clinical Trials of Penpulimab in Combination with Anlotinib for 1L HCC Co-developed by Sino Biopharmaceutical and Akeso Accepted for Presentation at ASCO Annual Meeting |
| Sino Biopharmaceutical Limited (HKEX: 1177), a leading, innovative research and development ("R&D") driven pharmaceutical conglomerate in the PRC, has announced that the abstracts on phase II study on clinical efficacy and safety of Penpulimab more info >> |
|
| Monday, March 30, 2020 |
|
|
中国生物制药公布2019年年度业绩 |
| 中国领先的创新研发驱动型医药集团—中国生物制药有限公司(「中国生物制药」或「公司」,连同附属公司统称「集团」)(股票编号:1177)公布截至2019年12月31日止年度(「年度」)之财务业绩。 more info >> |
|
|
中國生物製藥公佈2019年年度業績 |
| 中國領先的創新研發驅動型醫藥集團—中國生物製藥有限公司(「中國生物製藥」或「公司」,連同附屬公司統稱「集團」)(股票編號:1177)公佈截至2019年12月31日止年度(「年度」)之財務業績。 more info >> |
|
|
Sino Biopharm Announces 2019 Annual Results |
| Sino Biopharmaceutical Limited ("Sino Biopharm" or the "Company", together with its subsidiaries, the "Group") (HKEX: 1177), a leading, innovative research and development driven pharmaceutical conglomerate in the PRC, has announced its financial results for the year ended 31 December 2019 ("the year"). more info >> |
|
| Tuesday, January 21, 2020 |
|
|
Asia-Pacific has Record Year for Clinical Trials says Novotech CRO |
| Novotech CRO the largest biotech CRO in the Asia-Pacific said the region has had a record year for number of studies, experienced world-class sites and investigators, and patient enrolment. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Maxon、リアルタイム建築ビジュアライゼーションソリューションでAEC市場に正式参入
Mar 17, 2026 23:05: JST
|
|
|
Maxon, 실시간 Archviz 솔루션으로 AEC 시장 공식 진출
Mar 17, 2026 22:05 HKT/SGT
|
|
|
Maxon推出即時Archviz解決方案,正式進軍AEC市場
Mar 17, 2026 22:05 HKT/SGT
|
|
|
Maxon推出实时Archviz解决方案,正式进军AEC市场
Mar 17, 2026 22:05 HKT/SGT
|
|
|
Maxon Marks Its Official Entry Into the AEC Market With Its Real-Time Archviz Solution
Mar 17, 2026 22:05 HKT/SGT
|
|
|
FinHarbor Introduces Rapid-Deployment Neobank Platform for 30-Day Go-Live
Mar 17, 2026 22:00: JST
|
|
|
FinHarbor Introduces Rapid-Deployment Neobank Platform for 30-Day Go-Live
Mar 17, 2026 22:00 HKT/SGT
|
|
|
Geo Energy's Integrated Infrastructure Project Achieves 80% Completion; Secures Two Binding Term Sheets with Third Parties for 9 Million Tonnes Annual Haulage; Coal Prices Surge Amid Global Tensions
Mar 17, 2026 22:00 HKT/SGT
|
|
|
FILMART and EntertainmentPulse open today
Mar 17, 2026 21:41: JST
|
|
|
FILMART and EntertainmentPulse open today
Mar 17, 2026 21:41 JST
|
|
|
鍋圈(2517.HK)核心經營利潤勁增 四店齊發驅動長期成長
Mar 17, 2026 20:30 HKT/SGT
|
|
|
锅圈(2517.HK)核心经营利润劲增 四店齐发驱动长期成长
Mar 17, 2026 20:24 HKT/SGT
|
|
|
GUOQUAN FOOD (2517.HK) Surging core operating profit, Four Stores Jointly Advancing with Concerted Efforts for Long-Term Growth
Mar 17, 2026 20:15 HKT/SGT
|
|
|
TANAKA PRECIOUS METAL GROUP Provides Medals, Commemorative Items, and Trophies as Category Sponsor (Awards Ceremonies) for the LIGA.i Blind Soccer Top League 2025
Mar 17, 2026 21:00 JST
|
|
|
Eisai Established the Global Capability Centre in Visakhapatnam, India, to Standardize Global IT Infrastructure Operations and Digital Transformation
Mar 17, 2026 19:49 JST
|
|
|
|
|
More News >> |
|
|
|
|
|